A COMPLEX PEDIATRIC CASE OF RECURRENT SEVERE IGA VASCULITIS WITH MULTISYSTEM INVOLVEMENT: CLINICAL ANALYSIS AND THERAPEUTIC CHALLENGES
Keywords:
therapeutic considerations, vasculitis, diagnosticAbstract
IgA vasculitis (previously known as Henoch-Schönlein purpura) is a smallvessel vasculitis characterized by immune complex deposition, predominantly affecting children. While most cases resolve spontaneously, a significant minority may develop recurrent, severe forms of the disease, especially when kidney function is compromised. We present an 11-year-old boy with recurrent, systemic IgA vasculitis manifesting with nephrotic-range proteinuria, gastrointestinal symptoms, and persistent skin purpura. This case highlights the diagnostic complexity, pathophysiological underpinnings, and therapeutic considerations in managing refractory IgA vasculitis in pediatric patients.
References
Chen, T., et al. (2018). Efficacy of
mycophenolate mofetil in children with severe
Henoch-Schönlein purpura nephritis. Pediatrics
International, 60(3), 227–232.
Kawasaki, Y., et al. (2011). Clinical outcomes in
childhood IgA vasculitis nephritis: Risk factors
and treatment efficacy. Pediatric Nephrology,
(6), 931–936.
Koskela, M., et al. (2019). Prognostic markers
in Henoch-Schönlein purpura nephritis. Clinical
Kidney Journal, 12(5), 643–650.
Moldoveanu, Z., et al. (2008). Elevated serum
levels of galactose-deficient IgA1 in patients
with IgA nephropathy. Kidney International,
(11), 1148–1154.
Ruperto, N., et al. (2020). Rituximab therapy in
children with refractory IgA vasculitis. Pediatric
Rheumatology Online Journal, 18(1), 71.
Suzuki, H., et al. (2011). The pathophysiology
of IgA nephropathy. Journal of the American
Society of Nephrology, 22(10), 1795–1803.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Guloyim S. Avezova
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
